Longview Acquisition Corp II Cl A (LGV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGV | TMO | ISRG | ALC | IQV |
| Company | Longview Acquisition Corp II Cl A | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Alcon Inc | Iqvia Holdings Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NYSE | NYSE |
| Open | 10.09 | 604.56 | 488.25 | 99.02 | 234.77 |
| High | 10.09 | 620.54 | 490.95 | 99.41 | 236.99 |
| Low | 10.09 | 604.56 | 484.76 | 98.58 | 233.21 |
| Last | 10.09 | 619.33 | 486.33 | 99.08 | 236.23 |
| Change | -0.01 | +19.55 | +1.94 | +0.31 | +4.52 |
| % Change | -0.10% | +3.26% | +0.40% | +0.31% | +1.95% |
| Volume | 100 | 1,312,900 | 871,600 | 462,700 | 718,000 |
| 20-Day Average Volume | 639,690 | 1,295,955 | 1,209,280 | 754,275 | 1,320,000 |
| Previous Close | 10.10 | 599.78 | 484.39 | 98.77 | 231.71 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.04 | 613.09 | 485.46 | 97.43 | 241.93 |
| 20-Day Raw Stochastic | 71.43% | 73.18% | 67.36% | 71.98% | 27.23% |
| 20-Day Relative Strength | 69.88% | 56.03% | 55.93% | 59.16% | 47.00% |
| Weighted Alpha | +3.70 | +23.51 | +65.43 | +33.02 | +16.68 |
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.45% since 12/07/22 | -0.15% since 09/19/24 | -0.75% since 09/19/24 | +0.76% since 09/19/24 | -3.43% since 09/19/24 |
| Low | 9.94 on 12/13/22 | 596.00 on 09/25/24 | 480.16 on 09/20/24 | 96.75 on 09/20/24 | 230.00 on 09/25/24 |
| High | 10.15 on 12/13/22 | 620.54 on 09/26/24 | 491.83 on 09/23/24 | 99.41 on 09/26/24 | 245.20 on 09/23/24 |
| 1-Month | |||||
| %Chg | +0.90% since 11/14/22 | +2.27% since 08/26/24 | +1.49% since 08/26/24 | +4.08% since 08/26/24 | -4.69% since 08/26/24 |
| Low | 9.94 on 12/13/22 | 596.00 on 09/25/24 | 466.00 on 09/06/24 | 93.89 on 09/06/24 | 230.00 on 09/25/24 |
| High | 10.15 on 12/13/22 | 627.88 on 09/10/24 | 496.18 on 09/13/24 | 101.10 on 09/12/24 | 252.88 on 08/29/24 |
| 3-Month | |||||
| %Chg | +2.44% since 09/14/22 | +10.96% since 06/26/24 | +9.89% since 06/26/24 | +10.48% since 06/26/24 | +11.86% since 06/26/24 |
| Low | 9.81 on 09/29/22 | 528.37 on 07/09/24 | 413.82 on 07/18/24 | 87.79 on 07/10/24 | 205.06 on 07/05/24 |
| High | 10.15 on 12/13/22 | 627.88 on 09/10/24 | 496.18 on 09/13/24 | 101.10 on 09/12/24 | 252.88 on 08/29/24 |
| 6-Month | |||||
| %Chg | +3.38% since 06/14/22 | +8.88% since 03/26/24 | +22.31% since 03/26/24 | +19.91% since 03/26/24 | -4.65% since 03/26/24 |
| Low | 9.76 on 06/15/22 | 528.37 on 07/09/24 | 364.17 on 04/19/24 | 77.54 on 04/30/24 | 205.06 on 07/05/24 |
| High | 10.15 on 12/13/22 | 627.88 on 09/10/24 | 496.18 on 09/13/24 | 101.10 on 09/12/24 | 253.84 on 04/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 870,263 | 228,945,632 | 171,813,136 | 48,703,484 | 42,217,564 |
| Shares Outstanding, K | 86,250 | 381,716 | 354,700 | 493,100 | 182,200 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 9,455,000,000 | 14,984,000,000 |
| Annual Net Income | 7,400,000 | 5,995,000,000 | 1,798,000,000 | 974,000,000 | 1,358,000,000 |
| Last Quarter Sales | 0 | 10,541,000,000 | 2,009,900,000 | 2,496,000,000 | 3,814,000,000 |
| Last Quarter Net Income | 2,810,000 | 1,547,000,000 | 526,900,000 | 223,000,000 | 363,000,000 |
| 60-Month Beta | 0.05 | 0.78 | 1.39 | 0.98 | 1.49 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/14/22 | 5.37 on 07/24/24 | 1.78 on 07/18/24 | 0.74 on 08/20/24 | 2.64 on 07/22/24 |
| Latest Earnings Date | N/A | 10/23/24 | 10/17/24 | 11/12/24 | 11/06/24 |
| Most Recent Dividend | N/A | 0.390 on 09/13/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/13/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.02 | 97.46 | 34.15 | 24.75 |